Optimisation of electrotransfer of plasmid into skeletal muscle by pretreatment with hyaluronidase – increased expression with reduced muscle damage
暂无分享,去创建一个
E. Signori | JM McMahon | E Signori | KE Wells | VM Fazio | DJ Wells | K. Wells | D. Wells | J. McMahon | V. Fazio
[1] 邊見 弘明,et al. A Toll-like receptor recognizes bacterial DNA , 2003 .
[2] H. Schaff,et al. Exogenous hyaluronidase induces release of nitric oxide from the coronary endothelium. , 2000, The Journal of thoracic and cardiovascular surgery.
[3] G. Ciliberto,et al. Gene electrotransfer results in a high-level transduction of rat skeletal muscle and corrects anemia of renal failure. , 2000, Human gene therapy.
[4] R. Hällgren,et al. Hyaluronidase Can Be Used to Reduce Interstitial Edema in the Presence of Heparin , 2000, Journal of cardiovascular pharmacology and therapeutics.
[5] L. Mir,et al. Efficient DNA electrotransfer into tumors. , 2000, Bioelectrochemistry.
[6] M J Jaroszeski,et al. Theory and in vivo application of electroporative gene delivery. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.
[7] P. Lipsky,et al. The Role of Cell Surface Receptors in the Activation of Human B Cells by Phosphorothioate Oligonucleotides1 , 2000, The Journal of Immunology.
[8] N. Ferry,et al. Hyaluronidase enhances recombinant adeno-associated virus (rAAV)-mediated gene transfer in the rat skeletal muscle , 2000, Gene Therapy.
[9] H. Madry,et al. Efficient lipid-mediated gene transfer to articular chondrocytes , 2000, Gene Therapy.
[10] R. Schwartz,et al. Myogenic expression of an injectable protease-resistant growth hormone–releasing hormone augments long-term growth in pigs , 1999, Nature Biotechnology.
[11] D. Scherman,et al. Erythropoietin secretion and physiological effect in mouse after intramuscular plasmid DNA electrotransfer , 1999, Journal of Gene Medicine.
[12] R. Cortese,et al. Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[13] M. Bureau,et al. High-efficiency gene transfer into skeletal muscle mediated by electric pulses. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[14] I. Mathiesen. Electropermeabilization of skeletal muscle enhances gene transfer in vivo , 1999, Gene Therapy.
[15] M. Fiszman,et al. Gene delivery to the myocardium by intrapericardial injection , 1999, Gene Therapy.
[16] C. Halbert,et al. Successful Readministration of Adeno-Associated Virus Vectors to the Mouse Lung Requires Transient Immunosuppression during the Initial Exposure , 1998, Journal of Virology.
[17] H. Mischak,et al. CpG‐DNA‐specific activation of antigen‐presenting cells requires stress kinase activity and is preceded by non‐specific endocytosis and endosomal maturation , 1998, The EMBO journal.
[18] A. Krieg,et al. Rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA. , 1998, Journal of immunology.
[19] T. Jakob,et al. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. , 1998, Journal of immunology.
[20] K. Wells,et al. Inflammatory responses following direct injection of plasmid DNA into skeletal muscle , 1998, Gene Therapy.
[21] D. Wells,et al. Evaluation of plasmid DNA for in vivo gene therapy: factors affecting the number of transfected fibers. , 1998, Journal of pharmaceutical sciences.
[22] L. Turka,et al. Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig , 1998, Gene Therapy.
[23] R. K. Evans,et al. Analysis of plasmid DNA from a pharmaceutical perspective. , 1998, Journal of pharmaceutical sciences.
[24] J. Wolff,et al. The efficient expression of intravascularly delivered DNA in rat muscle , 1998, Gene Therapy.
[25] L. Manzel,et al. Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds. , 1998, Journal of immunology.
[26] H. Aihara,et al. Gene transfer into muscle by electroporation in vivo. , 1998, Nature biotechnology.
[27] H. Herweijer,et al. High expression of naked plasmid DNA in muscles of young rodents. , 1997, Human molecular genetics.
[28] James M. Wilson,et al. Recombinant adeno-associated virus for muscle directed gene therapy , 1997, Nature Medicine.
[29] R. Samulski,et al. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector , 1996, Journal of virology.
[30] K. Campbell,et al. In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genes. , 1996, Gene therapy.
[31] A. Fassati,et al. Transplantation of retroviral producer cells for in vivo gene transfer into mouse skeletal muscle. , 1996, Human gene therapy.
[32] F. Szoka,et al. Characterization of plasmid DNA transfer into mouse skeletal muscle: evaluation of uptake mechanism, expression and secretion of gene products into blood. , 1996, Gene therapy.
[33] A. Fassati,et al. Efficiency of in vivo gene transfer using murine retroviral vectors is strain-dependent in mice. , 1995, Human gene therapy.
[34] S. Parker,et al. Cancer gene therapy using plasmid DNA: pharmacokinetic study of DNA following injection in mice. , 1995, Human gene therapy.
[35] G. Bishop,et al. CpG motifs in bacterial DNA trigger direct B-cell activation , 1995, Nature.
[36] J. Wolff,et al. Pharmacological enhancement of in vivo foreign gene expression in muscle. , 1994, Gene Therapy.
[37] A. Picard,et al. Gene transfer in regenerating muscle. , 1994, Human gene therapy.
[38] B. Demeneix,et al. Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle. , 1993, Human gene therapy.
[39] D. Wells. Improved gene transfer by direct plasmid injection associated with regeneration in mouse skeletal muscle , 1993, FEBS letters.
[40] M. Perricaudet,et al. Long–term correction of mouse dystrophic degeneration by adenovirus–mediated transfer of a minidystrophin gene , 1993, Nature genetics.
[41] A. Rundell,et al. Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice. , 1993, Human gene therapy.
[42] B. Demeneix,et al. Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression. , 1993, Human gene therapy.
[43] D. Wells,et al. Age and sex influence expression of plasmid DNA directly injected into mouse skeletal muscle , 1992, FEBS letters.
[44] G. Repetto,et al. Direct gene transfer into nonhuman primate myofibers in vivo. , 1992, Human gene therapy.
[45] K. Davies,et al. Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs , 1991, Nature.
[46] G. Acsadi,et al. Direct gene transfer into mouse muscle in vivo. , 1990, Science.
[47] D. Jenkins,et al. 3-Aminopropyltriethoxysilane (APES): a new advance in section adhesion. , 1987, Journal of clinical pathology.
[48] T. Dubensky,et al. Direct transfection of viral and plasmid DNA into the liver or spleen of mice. , 1984, Proceedings of the National Academy of Sciences of the United States of America.